Myriad Genetics Q3 2022 Earnings Preview
Oct. 31, 2022 12:14 PM ETMyriad Genetics, Inc. (MYGN)By: SA News Team
- Myriad Genetics (NASDAQ:MYGN) is scheduled to announce Q3 earnings results on Tuesday, November 1st, before market open.
- The consensus EPS Estimate is -$0.08 and the consensus Revenue Estimate is $170.37M (+1.8% Y/Y).
- Over the last 2 years, MYGN has beaten EPS estimates 75% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 6 downward. Revenue estimates have seen 1 upward revision and 3 downward.